熱門資訊> 正文
Tango Therapeutics获得2.25亿美元融资
2025-10-23 19:33
- Tango Therapeutics (NASDAQ:TNGX) has priced an underwritten offering of 21,023,337 shares of common stock and pre-funded warrants to purchase up to 3,226,458 shares.
- The common stock is priced at $8.66 per share, while each pre-funded warrant is priced at $8.659. The offering is expected to generate approximately $210 million in gross proceeds and is scheduled to close on or around October 24, 2025, subject to customary closing conditions.
- In addition, Tango has entered into a private investment in public equity (PIPE) agreement, selling 1,732,101 shares of common stock at $8.66 per share. The PIPE is expected to bring in approximately $15 million in gross proceeds.
- TNGX +17.7% premarket to $10.19
- Source: Press Release
More on Tango Therapeutics
- Summit draws Neutral view on risk/reward setup as Piper initiates biotech cancer names
- Seeking Alpha’s Quant Rating on Tango Therapeutics
- Historical earnings data for Tango Therapeutics
- Financial information for Tango Therapeutics
推薦文章
美股機會日報 | 又來禁令？傳美政府禁止英偉達向中國出售最新降規版AI芯片；橋水達里奧：美聯儲降息是在助長泡沫！
一周財經日曆 | 財報重磅周！騰訊、京東、中芯國際下周四公佈業績；美國10月CPI、PPI攜零售數據來襲
一周IPO | 旺山旺水一手狂賺近萬港元，明略科技首日股價翻倍；百利天恆、中偉新材火熱招股中
華盛早報 | 美股全線大跌！OpenAI高管發言引發"AI圈"風暴；馬斯克拿下「萬億薪酬包」
AI應用概念股財報大PK：績后陷「冰火兩重天」，哪些公司經受住了考驗？
美股機會日報 | 馬斯克能否留下？萬億美元薪酬方案投票即將揭曉；英偉達黃仁勛：中國將贏得人工智能競賽！
美股七巨頭Q3成績單：砸錢不手軟！科技巨頭狂投AI；英偉達尚未公佈業績，已是最大贏家？
一周財經日曆 | 美國政府繼續停擺，大小非農能否如期發佈？IPO火爆，6只港股即將上市；美股進入冬令時
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
